CASE DISCUSSION

Liquid Biopsies: Revolutionizing Cancer Detection

Presented from India by Dr. Srinath Bharadwaj

Likes

2429

Views

121

Bookmarks

Case Description

Liquid biopsies represent a groundbreaking advancement in cancer detection, offering a non-invasive alternative to traditional tissue biopsies. These tests analyze circulating tumor DNA (ctDNA) or other biomarkers in blood to identify genetic mutations or alterations associated with cancer. Liquid...

Case Summary

Liquid biopsy is an evolving technique that aims to replace traditional tissue biopsies in cancer management. Tissue biopsies involve cutting a piece of solid tissue for examination, while liquid biopsies primarily use blood samples (or other body fluids) to detect cancer-related materials. One major problem with tissue biopsy is tumor heterogeneity, where different parts of a tumor have different genetic makeups.

Speaker Profile

Dr. Srinath Bharadwaj

Consultant, Medical Oncology and Haematology, Apollo Cancer Institutes, Jubilee Hills, Hyderabad

Dr. Srinath Bharadwaj R is a medical oncologist and hematologist currently working as a consultant at Apollo Cancer Institutes in Hyderabad, Telangana. He has extensive academic qualifications, including a DM in Medical Oncology and an MD in Radiation Oncology.

Disclosures

Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.